Tarveda Therapeutics tarveda.com


Public list: Smart Money VCs (6327) Pharma Startups (4729)

Tarveda Therapeutics, fka Blend Therapeutics, is a biopharmaceutical company discovering and developing Pentarins as a new class of targeted anti-cancer medicines to advance the treatment of patients with solid tumor cancers. Tarveda's lead Pentarin drug candidate, PEN-221, is a miniaturized biologic drug conjugate that targets the somatostatin receptor for treatment of patients with neuroendocrine cancers including small cell lung cancer. Tarveda's strategy includes developing its own proprieta...Show all

Tarveda Therapeutics, fka Blend Therapeutics, is a biopharmaceutical company discovering and developing Pentarins as a new class of targeted anti-cancer medicines to advance the treatment of patients with solid tumor cancers. Tarveda's lead Pentarin ...Show all

Company (Alive / Active)

Phone: 617-923-4100

Fax:

134 Coolidge Avenue

Watertown, 02472
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Tarveda Therapeutics $113.8M Feb 2, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Tarveda Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Targeted conjugates and particles and formulations thereof Dec 16, 2016 Sep 05, 2017 Patent
Cabazitaxel-platinum nanoparticles and methods of using same Mar 17, 2014 Nov 01, 2016 Patent
Targeted conjugates and particles and formulations thereof Jul 18, 2017 Application
Targeted conjugates and particles and formulations thereof Jun 30, 2015 Application
Nanoparticle diagnostic and methods for treating disease Jul 30, 2014 Application